Wellcome Trust Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
University of Southampton Featured PhD Programmes
University of Oxford Featured PhD Programmes
University of East Anglia Featured PhD Programmes

Novel probes for investigating the tumour microenvironment and tissue targeting

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  • Full or part time
    Dr G Bhalay
    Dr N Valeri
    Dr S Hoelder
  • Application Deadline
    No more applications being accepted
  • Funded PhD Project (Students Worldwide)
    Funded PhD Project (Students Worldwide)

About This PhD Project

Project Description

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes.
We are committed to attracting and developing the best minds in the world to join us in our mission—to make the discoveries that defeat cancer.

The tumour microenvironment is the cellular environment in which the tumour exists and plays an important role in cancer progression and metastasis. Probe compounds that allow us to ‘see’ into cells are useful for basic biology research as well as for the diagnosis and treatment of disease. An ideal probe must be sensitive and selective towards a biological effector as well as being capable of providing a spatially resolved response in order to monitor dynamic processes within a relevant timescale. This project aims to use chemistry and medicinal chemistry approaches for increasing the half-life of the imaging agent through covalent adduct formation or by lowering passive permeability. Our prototype reaction-based probes are designed to respond chemoselectively with analytes in the tumour microenvironment such as hydrogen peroxide, hydrogen sulphide or CYP-reductase.
We anticipate the application of these reaction-based probes for basic biology research as well clinically for visualising tumours where their longer residency may positively affect image contrast and their biased tissue distribution could benefit the patient by lowering exposure of healthy tissue to radioligand. Prospective probes will be evaluated in cell-based models through collaboration with researchers at the ICR. Proof-of-concept studies will be performed in CHO cells and afterwards in colorectal and breast cancer cell lines. Finally, we will test reaction-based probes in 3D organoid mono and co-culture derived from multiple metastatic deposits of patients with metastatic bowel and gastroesophageal cancers.

Funding Notes

Students receive an annual stipend, currently £21,000 per annum, as well as having tuition fees (both UK/EU and overseas) and project costs paid for the four-year duration. We are open to applications from any eligible candidates and are committed to attracting and developing the best minds in the world.

Candidates must have a first class or upper second class honours BSc Honours/MSc in Biochemistry or Chemistry.

FindAPhD. Copyright 2005-2019
All rights reserved.